Natriuretic Peptide-Global Market Status and Trend Report 2013-2023
Report Summary
Natriuretic Peptide-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Natriuretic Peptide industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Natriuretic Peptide 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Natriuretic Peptide worldwide, with company and product introduction, position in the Natriuretic Peptide market
Market status and development trend of Natriuretic Peptide by types and applications
Cost and profit status of Natriuretic Peptide, and marketing status
Market growth drivers and challenges
The report segments the global Natriuretic Peptide market as:
Global Natriuretic Peptide Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Natriuretic Peptide Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
0.1-1000 pg/Ml
0.31-20 ng/Ml
Global Natriuretic Peptide Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Medical Care
Others
Global Natriuretic Peptide Market: Manufacturers Segment Analysis (Company and Product introduction, Natriuretic Peptide Sales Volume, Revenue, Price and Gross Margin):
Raybiotech
Aviva Systems Biology
AssayPro
Biomatik
Novus Biologicals
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Natriuretic Peptide-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Natriuretic Peptide industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Natriuretic Peptide 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Natriuretic Peptide worldwide, with company and product introduction, position in the Natriuretic Peptide market
Market status and development trend of Natriuretic Peptide by types and applications
Cost and profit status of Natriuretic Peptide, and marketing status
Market growth drivers and challenges
The report segments the global Natriuretic Peptide market as:
Global Natriuretic Peptide Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Natriuretic Peptide Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
0.1-1000 pg/Ml
0.31-20 ng/Ml
Global Natriuretic Peptide Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Medical Care
Others
Global Natriuretic Peptide Market: Manufacturers Segment Analysis (Company and Product introduction, Natriuretic Peptide Sales Volume, Revenue, Price and Gross Margin):
Raybiotech
Aviva Systems Biology
AssayPro
Biomatik
Novus Biologicals
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF NATRIURETIC PEPTIDE
1.1 Definition of Natriuretic Peptide in This Report
1.2 Commercial Types of Natriuretic Peptide
1.2.1 0.1-1000 pg/Ml
1.2.2 0.31-20 ng/Ml
1.3 Downstream Application of Natriuretic Peptide
1.3.1 Medical Care
1.3.2 Others
1.4 Development History of Natriuretic Peptide
1.5 Market Status and Trend of Natriuretic Peptide 2013-2023
1.5.1 Global Natriuretic Peptide Market Status and Trend 2013-2023
1.5.2 Regional Natriuretic Peptide Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Natriuretic Peptide 2013-2017
2.2 Sales Market of Natriuretic Peptide by Regions
2.2.1 Sales Volume of Natriuretic Peptide by Regions
2.2.2 Sales Value of Natriuretic Peptide by Regions
2.3 Production Market of Natriuretic Peptide by Regions
2.4 Global Market Forecast of Natriuretic Peptide 2018-2023
2.4.1 Global Market Forecast of Natriuretic Peptide 2018-2023
2.4.2 Market Forecast of Natriuretic Peptide by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Natriuretic Peptide by Types
3.2 Sales Value of Natriuretic Peptide by Types
3.3 Market Forecast of Natriuretic Peptide by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Natriuretic Peptide by Downstream Industry
4.2 Global Market Forecast of Natriuretic Peptide by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Natriuretic Peptide Market Status by Countries
5.1.1 North America Natriuretic Peptide Sales by Countries (2013-2017)
5.1.2 North America Natriuretic Peptide Revenue by Countries (2013-2017)
5.1.3 United States Natriuretic Peptide Market Status (2013-2017)
5.1.4 Canada Natriuretic Peptide Market Status (2013-2017)
5.1.5 Mexico Natriuretic Peptide Market Status (2013-2017)
5.2 North America Natriuretic Peptide Market Status by Manufacturers
5.3 North America Natriuretic Peptide Market Status by Type (2013-2017)
5.3.1 North America Natriuretic Peptide Sales by Type (2013-2017)
5.3.2 North America Natriuretic Peptide Revenue by Type (2013-2017)
5.4 North America Natriuretic Peptide Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Natriuretic Peptide Market Status by Countries
6.1.1 Europe Natriuretic Peptide Sales by Countries (2013-2017)
6.1.2 Europe Natriuretic Peptide Revenue by Countries (2013-2017)
6.1.3 Germany Natriuretic Peptide Market Status (2013-2017)
6.1.4 UK Natriuretic Peptide Market Status (2013-2017)
6.1.5 France Natriuretic Peptide Market Status (2013-2017)
6.1.6 Italy Natriuretic Peptide Market Status (2013-2017)
6.1.7 Russia Natriuretic Peptide Market Status (2013-2017)
6.1.8 Spain Natriuretic Peptide Market Status (2013-2017)
6.1.9 Benelux Natriuretic Peptide Market Status (2013-2017)
6.2 Europe Natriuretic Peptide Market Status by Manufacturers
6.3 Europe Natriuretic Peptide Market Status by Type (2013-2017)
6.3.1 Europe Natriuretic Peptide Sales by Type (2013-2017)
6.3.2 Europe Natriuretic Peptide Revenue by Type (2013-2017)
6.4 Europe Natriuretic Peptide Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Natriuretic Peptide Market Status by Countries
7.1.1 Asia Pacific Natriuretic Peptide Sales by Countries (2013-2017)
7.1.2 Asia Pacific Natriuretic Peptide Revenue by Countries (2013-2017)
7.1.3 China Natriuretic Peptide Market Status (2013-2017)
7.1.4 Japan Natriuretic Peptide Market Status (2013-2017)
7.1.5 India Natriuretic Peptide Market Status (2013-2017)
7.1.6 Southeast Asia Natriuretic Peptide Market Status (2013-2017)
7.1.7 Australia Natriuretic Peptide Market Status (2013-2017)
7.2 Asia Pacific Natriuretic Peptide Market Status by Manufacturers
7.3 Asia Pacific Natriuretic Peptide Market Status by Type (2013-2017)
7.3.1 Asia Pacific Natriuretic Peptide Sales by Type (2013-2017)
7.3.2 Asia Pacific Natriuretic Peptide Revenue by Type (2013-2017)
7.4 Asia Pacific Natriuretic Peptide Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Natriuretic Peptide Market Status by Countries
8.1.1 Latin America Natriuretic Peptide Sales by Countries (2013-2017)
8.1.2 Latin America Natriuretic Peptide Revenue by Countries (2013-2017)
8.1.3 Brazil Natriuretic Peptide Market Status (2013-2017)
8.1.4 Argentina Natriuretic Peptide Market Status (2013-2017)
8.1.5 Colombia Natriuretic Peptide Market Status (2013-2017)
8.2 Latin America Natriuretic Peptide Market Status by Manufacturers
8.3 Latin America Natriuretic Peptide Market Status by Type (2013-2017)
8.3.1 Latin America Natriuretic Peptide Sales by Type (2013-2017)
8.3.2 Latin America Natriuretic Peptide Revenue by Type (2013-2017)
8.4 Latin America Natriuretic Peptide Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Natriuretic Peptide Market Status by Countries
9.1.1 Middle East and Africa Natriuretic Peptide Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Natriuretic Peptide Revenue by Countries (2013-2017)
9.1.3 Middle East Natriuretic Peptide Market Status (2013-2017)
9.1.4 Africa Natriuretic Peptide Market Status (2013-2017)
9.2 Middle East and Africa Natriuretic Peptide Market Status by Manufacturers
9.3 Middle East and Africa Natriuretic Peptide Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Natriuretic Peptide Sales by Type (2013-2017)
9.3.2 Middle East and Africa Natriuretic Peptide Revenue by Type (2013-2017)
9.4 Middle East and Africa Natriuretic Peptide Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF NATRIURETIC PEPTIDE
10.1 Global Economy Situation and Trend Overview
10.2 Natriuretic Peptide Downstream Industry Situation and Trend Overview
CHAPTER 11 NATRIURETIC PEPTIDE MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Natriuretic Peptide by Major Manufacturers
11.2 Production Value of Natriuretic Peptide by Major Manufacturers
11.3 Basic Information of Natriuretic Peptide by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Natriuretic Peptide Major Manufacturer
11.3.2 Employees and Revenue Level of Natriuretic Peptide Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 NATRIURETIC PEPTIDE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Raybiotech
12.1.1 Company profile
12.1.2 Representative Natriuretic Peptide Product
12.1.3 Natriuretic Peptide Sales, Revenue, Price and Gross Margin of Raybiotech
12.2 Aviva Systems Biology
12.2.1 Company profile
12.2.2 Representative Natriuretic Peptide Product
12.2.3 Natriuretic Peptide Sales, Revenue, Price and Gross Margin of Aviva Systems Biology
12.3 AssayPro
12.3.1 Company profile
12.3.2 Representative Natriuretic Peptide Product
12.3.3 Natriuretic Peptide Sales, Revenue, Price and Gross Margin of AssayPro
12.4 Biomatik
12.4.1 Company profile
12.4.2 Representative Natriuretic Peptide Product
12.4.3 Natriuretic Peptide Sales, Revenue, Price and Gross Margin of Biomatik
12.5 Novus Biologicals
12.5.1 Company profile
12.5.2 Representative Natriuretic Peptide Product
12.5.3 Natriuretic Peptide Sales, Revenue, Price and Gross Margin of Novus Biologicals
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF NATRIURETIC PEPTIDE
13.1 Industry Chain of Natriuretic Peptide
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF NATRIURETIC PEPTIDE
14.1 Cost Structure Analysis of Natriuretic Peptide
14.2 Raw Materials Cost Analysis of Natriuretic Peptide
14.3 Labor Cost Analysis of Natriuretic Peptide
14.4 Manufacturing Expenses Analysis of Natriuretic Peptide
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Natriuretic Peptide in This Report
1.2 Commercial Types of Natriuretic Peptide
1.2.1 0.1-1000 pg/Ml
1.2.2 0.31-20 ng/Ml
1.3 Downstream Application of Natriuretic Peptide
1.3.1 Medical Care
1.3.2 Others
1.4 Development History of Natriuretic Peptide
1.5 Market Status and Trend of Natriuretic Peptide 2013-2023
1.5.1 Global Natriuretic Peptide Market Status and Trend 2013-2023
1.5.2 Regional Natriuretic Peptide Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Natriuretic Peptide 2013-2017
2.2 Sales Market of Natriuretic Peptide by Regions
2.2.1 Sales Volume of Natriuretic Peptide by Regions
2.2.2 Sales Value of Natriuretic Peptide by Regions
2.3 Production Market of Natriuretic Peptide by Regions
2.4 Global Market Forecast of Natriuretic Peptide 2018-2023
2.4.1 Global Market Forecast of Natriuretic Peptide 2018-2023
2.4.2 Market Forecast of Natriuretic Peptide by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Natriuretic Peptide by Types
3.2 Sales Value of Natriuretic Peptide by Types
3.3 Market Forecast of Natriuretic Peptide by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Natriuretic Peptide by Downstream Industry
4.2 Global Market Forecast of Natriuretic Peptide by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Natriuretic Peptide Market Status by Countries
5.1.1 North America Natriuretic Peptide Sales by Countries (2013-2017)
5.1.2 North America Natriuretic Peptide Revenue by Countries (2013-2017)
5.1.3 United States Natriuretic Peptide Market Status (2013-2017)
5.1.4 Canada Natriuretic Peptide Market Status (2013-2017)
5.1.5 Mexico Natriuretic Peptide Market Status (2013-2017)
5.2 North America Natriuretic Peptide Market Status by Manufacturers
5.3 North America Natriuretic Peptide Market Status by Type (2013-2017)
5.3.1 North America Natriuretic Peptide Sales by Type (2013-2017)
5.3.2 North America Natriuretic Peptide Revenue by Type (2013-2017)
5.4 North America Natriuretic Peptide Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Natriuretic Peptide Market Status by Countries
6.1.1 Europe Natriuretic Peptide Sales by Countries (2013-2017)
6.1.2 Europe Natriuretic Peptide Revenue by Countries (2013-2017)
6.1.3 Germany Natriuretic Peptide Market Status (2013-2017)
6.1.4 UK Natriuretic Peptide Market Status (2013-2017)
6.1.5 France Natriuretic Peptide Market Status (2013-2017)
6.1.6 Italy Natriuretic Peptide Market Status (2013-2017)
6.1.7 Russia Natriuretic Peptide Market Status (2013-2017)
6.1.8 Spain Natriuretic Peptide Market Status (2013-2017)
6.1.9 Benelux Natriuretic Peptide Market Status (2013-2017)
6.2 Europe Natriuretic Peptide Market Status by Manufacturers
6.3 Europe Natriuretic Peptide Market Status by Type (2013-2017)
6.3.1 Europe Natriuretic Peptide Sales by Type (2013-2017)
6.3.2 Europe Natriuretic Peptide Revenue by Type (2013-2017)
6.4 Europe Natriuretic Peptide Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Natriuretic Peptide Market Status by Countries
7.1.1 Asia Pacific Natriuretic Peptide Sales by Countries (2013-2017)
7.1.2 Asia Pacific Natriuretic Peptide Revenue by Countries (2013-2017)
7.1.3 China Natriuretic Peptide Market Status (2013-2017)
7.1.4 Japan Natriuretic Peptide Market Status (2013-2017)
7.1.5 India Natriuretic Peptide Market Status (2013-2017)
7.1.6 Southeast Asia Natriuretic Peptide Market Status (2013-2017)
7.1.7 Australia Natriuretic Peptide Market Status (2013-2017)
7.2 Asia Pacific Natriuretic Peptide Market Status by Manufacturers
7.3 Asia Pacific Natriuretic Peptide Market Status by Type (2013-2017)
7.3.1 Asia Pacific Natriuretic Peptide Sales by Type (2013-2017)
7.3.2 Asia Pacific Natriuretic Peptide Revenue by Type (2013-2017)
7.4 Asia Pacific Natriuretic Peptide Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Natriuretic Peptide Market Status by Countries
8.1.1 Latin America Natriuretic Peptide Sales by Countries (2013-2017)
8.1.2 Latin America Natriuretic Peptide Revenue by Countries (2013-2017)
8.1.3 Brazil Natriuretic Peptide Market Status (2013-2017)
8.1.4 Argentina Natriuretic Peptide Market Status (2013-2017)
8.1.5 Colombia Natriuretic Peptide Market Status (2013-2017)
8.2 Latin America Natriuretic Peptide Market Status by Manufacturers
8.3 Latin America Natriuretic Peptide Market Status by Type (2013-2017)
8.3.1 Latin America Natriuretic Peptide Sales by Type (2013-2017)
8.3.2 Latin America Natriuretic Peptide Revenue by Type (2013-2017)
8.4 Latin America Natriuretic Peptide Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Natriuretic Peptide Market Status by Countries
9.1.1 Middle East and Africa Natriuretic Peptide Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Natriuretic Peptide Revenue by Countries (2013-2017)
9.1.3 Middle East Natriuretic Peptide Market Status (2013-2017)
9.1.4 Africa Natriuretic Peptide Market Status (2013-2017)
9.2 Middle East and Africa Natriuretic Peptide Market Status by Manufacturers
9.3 Middle East and Africa Natriuretic Peptide Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Natriuretic Peptide Sales by Type (2013-2017)
9.3.2 Middle East and Africa Natriuretic Peptide Revenue by Type (2013-2017)
9.4 Middle East and Africa Natriuretic Peptide Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF NATRIURETIC PEPTIDE
10.1 Global Economy Situation and Trend Overview
10.2 Natriuretic Peptide Downstream Industry Situation and Trend Overview
CHAPTER 11 NATRIURETIC PEPTIDE MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Natriuretic Peptide by Major Manufacturers
11.2 Production Value of Natriuretic Peptide by Major Manufacturers
11.3 Basic Information of Natriuretic Peptide by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Natriuretic Peptide Major Manufacturer
11.3.2 Employees and Revenue Level of Natriuretic Peptide Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 NATRIURETIC PEPTIDE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Raybiotech
12.1.1 Company profile
12.1.2 Representative Natriuretic Peptide Product
12.1.3 Natriuretic Peptide Sales, Revenue, Price and Gross Margin of Raybiotech
12.2 Aviva Systems Biology
12.2.1 Company profile
12.2.2 Representative Natriuretic Peptide Product
12.2.3 Natriuretic Peptide Sales, Revenue, Price and Gross Margin of Aviva Systems Biology
12.3 AssayPro
12.3.1 Company profile
12.3.2 Representative Natriuretic Peptide Product
12.3.3 Natriuretic Peptide Sales, Revenue, Price and Gross Margin of AssayPro
12.4 Biomatik
12.4.1 Company profile
12.4.2 Representative Natriuretic Peptide Product
12.4.3 Natriuretic Peptide Sales, Revenue, Price and Gross Margin of Biomatik
12.5 Novus Biologicals
12.5.1 Company profile
12.5.2 Representative Natriuretic Peptide Product
12.5.3 Natriuretic Peptide Sales, Revenue, Price and Gross Margin of Novus Biologicals
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF NATRIURETIC PEPTIDE
13.1 Industry Chain of Natriuretic Peptide
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF NATRIURETIC PEPTIDE
14.1 Cost Structure Analysis of Natriuretic Peptide
14.2 Raw Materials Cost Analysis of Natriuretic Peptide
14.3 Labor Cost Analysis of Natriuretic Peptide
14.4 Manufacturing Expenses Analysis of Natriuretic Peptide
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
